- Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance
Shabnam Malik et al, 2024, Cancer and Metastasis Reviews CrossRef - Black tea bioactive phytoconstituents realign NRF2 for anticancer activity in lung adenocarcinoma
Suchisnigdha Datta et al, 2023, Frontiers in Pharmacology CrossRef - Ferroptosis As Ultimate Target of Cancer Therapy
Yashiro Motooka et al, 2023, Antioxidants & Redox Signaling CrossRef - The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer carrying otherwise therapy-refractory mutations
Aditya Kulkarni et al, 2021, Oncotarget CrossRef - Imperfect Predictors for Lung Cancer Immunotherapy—A Field for Further Research
Kamila Wojas-Krawczyk et al, 2020, Frontiers in Oncology CrossRef - Underpinning the Cellular and Molecular Mechanisms with Nanotheranostics for Lung Cancer
Asiya Mahtab et al, 2021, Targeting Cellular Signalling Pathways in Lung Diseases CrossRef - Detoxifying effects of optimal hyperoxia (40% oxygenation) exposure on benzo[a]pyrene-induced toxicity in human keratinocytes
Yong Chan Kwon et al, 2020, Journal of Toxicology and Environmental Health, Part A CrossRef - CircKEAP1 Suppresses the Progression of Lung Adenocarcinoma via the miR-141-3p/KEAP1/NRF2 Axis
Yanbo Wang et al, 2021, Frontiers in Oncology CrossRef - Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer
Kexun Zhou et al, 2023, Frontiers in Immunology CrossRef